Assessing the risk of clinical fracture in men with non-metastatic prostate cancer receiving gonadotropin-releasing hormone agonist therapy

J of Urology 2006 Jan; 175(1):136-9; discussion 139

Authors

Smith M, Boyce S, Moyneur E, Duh MS, Raut M, Brandman J